News/ News/ R&D Chord gets $16m to challenge Alexion with oral NMOSD drug Phil Taylor Chord Therapeutics, financing, NMOSD, rare disease, switzerland 0 Comment Swiss biotech Chord Therapeutics has come out of stealth mode with a $16 million first-round financing that will Share X Chord gets $16m to challenge Alexion with oral NMOSD drug https://pharmaphorum.com/news/chord-gets-16m-to-challenge-alexion-with-oral-nmosd-drug/
Chord Therapeutics, financing, NMOSD, rare disease, switzerland
0 Comment
